Maybe we should look at WHYLet's see...developed in Mexico...used thousands of times...BUT...."In 2004, Boyer launched a clinical study of Anascorp in the U.S. The study, supervised by the FDA, included 28 participating hospitals. Nearly 2,000 Americans received the drug.One of the youngest American patients to receive it so far is 4-year-old Ryleigh Wagley. She was stung by a scorpion in her crib when she was just 25 days old.The Wagley family lives in rural eastern Arizona, more than two hours away from the nearest ICU. Luckily for Ryleigh, a small clinic in the nearby mining town of Morenci was part of the clinical study of Anascorp. Dr. Fred Fox, the physician who treated Ryleigh, says the antivenom helped saved her life."It took 8 years of 'clinical trials' at 28 hospitals and over 2000 patient trials...... to get approval...just granted this year on Aug 3........to bring this drug to the market.WOw...8 years of 'trials'......OMG..Can you imagine what those tests costs??????And with 150 cases or so a year serious enough to require treatment, how much overhead to pay for those trials has to be added into the cost per vial? Things the dims never think about when they write their 200,000 pages of NEW regulations every year....and add 100,000 new federal workers to oversea all the new regulations they can't even keep up with....t.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ra